Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gifford US Growth Trust Regulatory News (USA)

Share Price Information for Baillie Gifford US Growth Trust (USA)

Share Price is delayed by 15 minutes
Get Live Data
366.00    -0.50 (-0.14%)
Bid:
364.50
Ask:
366.00
Spread: 1.50 (0.412%)
Market Cap: £1.01b
USA Live PriceLast checked at - London Stock Exchange

Intraday Baillie Gifford US Growth Trust Share Chart

Net Asset Value(s)

13 Jan 2026 11:45

RNS Number : 7292O
Baillie Gifford US Growth Trust PLC
13 January 2026
 

Baillie Gifford US Growth Trust plc (USA)

12 January 2026

Legal Entity Identifier : 213800UM1OUWXZPKE539

 

 

Cum Par NAV

313.85p

 

 

 

Ex Par NAV

315.24p

 

 

 

 

Short-term borrowings are valued at par.

 

 

 

Net Asset Values are unaudited, and calculated in accordance with published accounting policies and AIC guidelines.

 

 

 

Cum Par NAV: Net asset value per share in pence, including income, with debt at par value.

Ex Par NAV: Net asset value per share in pence, excluding income, with debt at par value.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBBGDBXSBDGLX
Date   Source Headline
3rd Jun 202611:50 amRNSNet Asset Value(s)
3rd Jun 202610:02 amRNSHolding(s) in Company
2nd Jun 202611:46 amRNSNet Asset Value(s)
1st Jun 202612:38 pmRNSNet Asset Value(s)
29th May 202611:20 amRNSNet Asset Value(s)
28th May 202612:13 pmRNSHolding(s) in Company
28th May 202611:36 amRNSNet Asset Value(s)
27th May 202611:35 amRNSNet Asset Value(s)
26th May 202611:36 amRNSNet Asset Value(s)
26th May 20269:47 amRNSNet Asset Value(s)
26th May 20267:00 amRNSHolding(s) in Company
22nd May 202611:21 amRNSNet Asset Value(s)
21st May 202611:33 amRNSNet Asset Value(s)
20th May 202611:50 amRNSNet Asset Value(s)
19th May 202611:18 amRNSNet Asset Value(s)
18th May 202611:43 amRNSNet Asset Value(s)
15th May 202611:36 amRNSNet Asset Value(s)
14th May 202611:40 amRNSNet Asset Value(s)
13th May 202611:43 amRNSNet Asset Value(s)
12th May 20264:03 pmRNSHolding(s) in Company
12th May 202612:24 pmRNSNet Asset Value(s)
11th May 20263:00 pmRNSHolding(s) in Company
11th May 202611:06 amRNSNet Asset Value(s)
8th May 202611:47 amRNSNet Asset Value(s)
7th May 202612:01 pmRNSNet Asset Value(s)
6th May 202611:32 amRNSNet Asset Value(s)
5th May 202611:26 amRNSNet Asset Value(s)
5th May 20268:28 amRNSNet Asset Value(s)
1st May 20262:49 pmRNSNet Asset Value(s)
30th Apr 20264:06 pmRNSHolding(s) in Company
30th Apr 202611:21 amRNSNet Asset Value(s)
29th Apr 202611:20 amRNSNet Asset Value(s)
28th Apr 202611:41 amRNSNet Asset Value(s)
27th Apr 202612:40 pmRNSUpdate on NAV and Anthropic valuation
27th Apr 202612:26 pmRNSNet Asset Value(s)
24th Apr 20261:30 pmRNSNet Asset Value(s)
23rd Apr 20264:37 pmRNSHolding(s) in Company
23rd Apr 202611:56 amRNSNet Asset Value(s)
22nd Apr 202611:28 amRNSNet Asset Value(s)
21st Apr 202611:32 amRNSNet Asset Value(s)
20th Apr 202612:15 pmRNSNet Asset Value(s)
17th Apr 202612:04 pmRNSNet Asset Value(s)
16th Apr 202611:25 amRNSNet Asset Value(s)
15th Apr 202611:37 amRNSNet Asset Value(s)
14th Apr 202612:15 pmRNSNet Asset Value(s)
13th Apr 202611:33 amRNSNet Asset Value(s)
10th Apr 202611:33 amRNSNet Asset Value(s)
9th Apr 202611:39 amRNSNet Asset Value(s)
8th Apr 202611:33 amRNSNet Asset Value(s)
7th Apr 202612:20 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.